فضلا اضغط بالاسفل
يستعمل دواء مبيفيروباك 400مجم 28 اقراصmpiviropack 400mg 28 tablets anti-viral anti-viral
indications and usage: -it is a hepatitis c virus (hcv) nucleotide analog ns5b polymerase inhibitor indicated for the treatment of chronic hepatitis c (chc) infection as a component of a combination antiviral treatment regimen. -*efficacy has been established in subjects with hcv genotype 1 2 3 or 4 infection including those with hepatocellular carcinoma meeting milan criteria (awaiting liver transplantation) and those with hcv/hiv-1 co-infection. - -*dosage and administration: -* one 400 mg tablet taken once daily with or without food. -* should be used in combination with ribavirin or in combination with pegylated interferon and ribavirin for the treatment of chc. -recommended combination therapy: -hcv mono-infected and hcv/hiv-1 co-infected - treatment duration -genotype 1 or 4 sovaldi + peg-interferon alfa + ribavirin 12 weeks -genotype 2 so
تركيبة دواءمبيفيروباك 400مجم 28 اقراصmpiviropack 400mg 28 tablets
يتركب هذا الدواء من :sofosbuvir
الشركة المنتجة لدواءمبيفيروباك 400مجم 28 اقراصmpiviropack 400mg 28 tablets
هذا الدواء من انتاج شركة marcyrl co.
جرعة دواءمبيفيروباك 400مجم 28 اقراص
Welcome to Dlildwa, specifically the page of mpiviropack 400mg 28 tablets.
تم استعراض بدائل هذا الدواء 345 مرة